Description
WHAT IS IT?
It is an anorexigenic agent indicated as an adjuvant in the treatment of exogenous obesity with a Body Mass Index (BMI) greater than 30 kg/m2 or overweight with a BMI greater than 27 kg/m2 with some associated comorbidity (e.g. high blood pressure, dyslipidemia, type 2 diabetes mellitus, sleep apnea, osteoarthritis, etc.) accompanied by a low-calorie diet and exercise regimen.
RECOMMENDATIONS
Adolescents aged 18 years or older and adults: One 20 mg tablet, 30 to 60 minutes before breakfast and/or the main meal of the day for up to 6 months.
The last dose should not be given after 6:00 p.m.
To stop treatment, the dose should be gradually reduced until it is discontinued.
This withdrawal period may or may not be included in the 6 months of treatment. For example, the dose can be reduced as follows: the first week 3 doses, the second week two doses and the following two weeks one dose.
Reviews
There are no reviews yet.